Susceptibility of Fanconi’s Anemia Lymphoblasts to DNA-cross-linking and Alkylating Agents

Cancer Research

Volumn 42, Issue 10, 1982, Pages 4000-4006

  ishida, Ryoji ^a   Buchwald, Manuel ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ALKYLATING AGENT; BLEOMYCIN; BUTADIENE DIEPOXIDE; CARMUSTINE; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; LOMUSTINE; MELPHALAN; MESYLIC ACID ETHYL ESTER; MESYLIC ACID METHYL ESTER; METHYLNITRONITROSOGUANIDINE; MITOMYCIN C; SEMUSTINE;

CELL GROWTH; CELL LINE; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; DOSE RESPONSE; DRUG COMPARISON; DRUG CYTOTOXICITY; DRUG RESPONSE; DRUG SENSITIVITY; FANCONI ANEMIA; HEREDITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTOXICATION; LYMPHOBLAST; RETICULOENDOTHELIAL SYSTEM;

4-NITROQUINOLINE-1-OXIDE; ALKYLATING AGENTS; ANEMIA, APLASTIC; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOGENS; CELL LINE; CELL SURVIVAL; CROSS-LINKING REAGENTS; DNA; EPOXY COMPOUNDS; FANCONI ANEMIA; HUMAN; LYMPHOCYTES; MITOMYCIN; MITOMYCINS; NITROSOUREA COMPOUNDS; SUPPORT, NON-U.S. GOV'T; XERODERMA PIGMENTOSUM;

EID: 0020357892     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Arlett, C.F., and Lehmann, A.R. Human disorders showing increased sensitivity to the induction of genetic damage. Annu. Rev. Genet., 12: 95–115, 1978.
2. Auerbach, A.D., and Wolman, S.R. Susceptibility of Fanconi’s anemia fibroblasts to chromosome damage by carcinogens. Nature (Lond.), 261: 494–496, 1976.
3. Berger, R., Bernheim, A., Coniat, M.L., Vecchione, D., and Schaison, G. Nitrogen mustard-induced chromosome breakage: a tool for Fanconi’s anemia diagnosis. Cancer Genet. Cytogenet., 2: 269–274, 1980.
4. Berger, R., Bernheim, A., Gluckman, E., and Gusselbrecht, C. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anemia patients. Br. J. Haematol., 45: 565–568, 1980.
5. Brox, L.W., Gowans, B. and Belch. A. L-Phenylalanine mustard (melphalan) uptake and cross-linking in the RPMI 6410 human lymphoblastoid cell line. Cancer Res., 40: 1169–1172, 1980.
6. Buchwald, M., Ullman, B., and Martin, D.W., Jr. Biochemical and genetic analysis of AMP deaminase in cultured mammalian cells. J. Biol. Chem., 256: 10346–10353, 1981.
7. Byfield, J.E., and Calabro-Jones, P.M. Carrierdependent and carrier-independent transport of anti-cancer alkylating agents. Nature (Lond.), 294: 281–283, 1981.
8. Cleaver, J.E. Defective repair replication of DNA in xeroderma pigmentosum. Nature (Lond.), 218: 652–656, 1968.
9. Day, R.S., III, Ziolkowski. C.H.J. Scudiero, D.A., Meyer, S.A., Lubiniecki, A.S., Girardi, A.J., Galloway, S.M., and Bynum, G.D. Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Nature (Lond.), 288: 724–727, 1980.
10. Elmore, E., and Swift, M. Growth of cultured cells from patients with Fanconi anemia. J. Cell. Physiol., 87: 229–239, 1976.
11. Erickson, L.C., Laurent, G., Sharkey, N.A., and Kohn, K.W. DNA crosslinking and monoadduct repair in nitrosourea-treated human tumour cells. Nature (Lond.), 288: 727–729, 1980.
12. Ewig, R.A.G., and Kohn, D.W. DNA-protein cross-linking and DNA interstrand cross-linking by haloethylnitrosourea in L1210 cells. Cancer Res., 38: 3197–3202, 1978.
13. Fanconi, G. Familial constitutional panmyelocytopathy, Fanconi’s anemia (FA). I. Clinical aspects. Semin. Hematol., 4: 233–240, 1967.
14. Fornace, A.J., Jr., Little, J.B., and Weichselbaum, R.R. DNA repair in a Fanconi’s anemia fibroblast cell strain. Biochim. Biophys. Acta, 561: 99–109, 1979.
15. Fujiwara, Y., and Tatzumi, M. Repair of mitomycin C damage to DNA in mammalian cells and its impairment in Fanconi’s anemia cells. Biochem. Biophys. Res. Commun., 66: 592–598, 1975.
16. Fujiwara Y., Tatsumi, M., and Sasaki, M.S. Cross-link repair in human cells and its possible defect in Fanconi’s anemia cells. J. Mol. Biol., 113: 635–649, 1977.
17. German, J. Genes which increase chromosomal instability in somatic cells and predispose to cancer. Prog. Med. Genet., 8: 61–101, 1972.
18. German, J., Schonberg, S., Louie, E., and Chaganti, R.S.K. Bloom’s syndrome. IV. Sister chromatid exchanges in lymphocytes. Am. J. Hum. Genet., 29: 248–255, 1977.
19. Glade, P.R., and Broder, S.W. Preparation and care of established human lymphoid cell lines. In: B.R. Bloom and P.R. Glade (eds.), In Vitro Methods in Cell-Mediated Immunity, pp. 561–570. New York: Academic Press, Inc., 1971.
20. Heddle, J.A., Lue, C.B., Saunders, E.F., and Benz, R.D. Sensitivity to five mutagens in Fanconi’s anemia as measured by the micronucleus method. Cancer Res., 38: 2983–2988, 1978.
21. Horacek, P., and Drobnik, J. Interaction of cis-dichlorodiamine platinum(ll) with DNA. Biochim. Biophys. Acta, 254: 341–347, 1971.
22. Iyer, V.N., and Szybalski, W. Mitomycins and porfiromycin: chemical mechanism of activation and cross-linking of DNA. Science (Wash.D.C.), 145: 55–58, 1964.
23. Kauffmann, M.H., Schweiger, M., Wagner, E.F., and Sperling, K. Deficiency of DNA ligase activity in Fanconi’s anemia. Hum. Genet., 45: 25–32, 1978.
24. Kaye, J., Smith, C.A., and Hanawalt, P.C. DNA repair in human cells containing photoadducts of 8-methoxypsoralen or angelicin. Cancer Res., 40: 696–702, 1980.
25. Kohn, K.W. Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas. Cancer Res., 37: 1450–1454, 1977.
26. Kondo, S., Ichikawa, H., Iwo, K., and Kato, T. Base-change mutagenesis and prophage induction in strains of Escherichia coli with different DNA repair capacities. Genetics, 66: 187–217, 1970.
27. Kuo, M. T., and Haidle, C.W. Characterization of chain breakage in DNA induced by bleomycin. Biochem. Biophys. Acta, 335: 109–114, 1973.
28. Latt, S.A., Stetler, E., Jeugens, L.A., Buchanan, A.R., and Gerald, P.S. Induction by alkylating agents of sister chromatid exchanges and chromatid breaks in Fanconi’s anemia. Proc. Natl. Acad. Sci. U.S.A., 72: 4066–4070, 1975.
29. Lawley, P.D., and Brookes, P. Interstrand cross-linking of DNA by difunctional alkylating agents. J. Mol. Biol., 25: 143–160, 1967.
30. Moshell, A.N., Tarone, R.E., Newfield, S.A., Andrews, A.D., and Robbins, J.H.A simple and rapid method for evaluating the survival of xeroderma pigmentosum lymphoid cell lines after irradiation with ultraviolet light. In Vitro (Rockville). 17: 299–307, 1981.
31. Muller, W.E.G., and Zahn, R.K. Bleomycin: mode of action of DNA. Gann Monogr., 19: 51–61, 1976.
32. Parsons, P.G., Carter, F.B., Morrison, L., and Mary, S.R. Mechanisms of melphalan resistance developed in vitro in human melanoma cells. Cancer Res., 41: 1525–1534, 1981.
33. Ross, W.E., Ewig, R.A.G., and Kohn, K.W. Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links. Cancer Res., 38: 1502–1506, 1978.
34. Sasaki, M.S. Is Fanconi’s anemia defective in a process essential to the repair of DNA cross-links? Nature (Lond.), 257: 501–503, 1975.
35. Sasaki, M.S. Fanconi’s anemia: a condition possibly associated with a defective DNA repair. In: P.C. Hanawalt. E.C. Friedberg, and C.F. Fox (eds.), DNA Repair Mechanism, pp. 675–684. New York: Academic Press, Inc., 1978.
36. Sasaki, M.S., and Tonomura, A. A high susceptibility of Fanconi’s anemia to chromosome breakage by DNA cross-linking agents. Cancer Res., 33: 1829–1836, 1973.
37. Setlow, R.B. Repair deficient human disorders and cancer. Nature (Lond.), 271: 713–717, 1978.
38. Shiloh, Y., and Becker, Y. Kinetics of O6-methylguanine repair in human normal and ataxia telangiectasia cell lines and correlation of repair capacity with cellular sensitivity to methylating agents. Cancer Res., 41: 5114–5120, 1981.
39. Singer, B. The chemical effects of nucleic acid alkylation and their relation to mutagenesis and carcinogenesis. Prog. Nucleic Acid Res. Mol. Biol., 15: 219–284, 1975.
40. Sklar, R., and Stauss, B. Removal of 06-methylguanine from DNA of normal and xeroderma pigmentosum-derived lymphoblastoid lines. Nature (Lond.), 289: 417–420, 1981.
41. Stanners, C.P., Eliceiri, G.L., and Green, H. Two types of ribosomes in mouse-hamster hybrid cells. Nat. New Biol., 230: 52–54, 1971.
42. Surya, Y.A., Rosenfeld, J.M., and Hillcoat, B.L. Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard. Cancer Treat. Rep., 62: 23–29, 1978.
43. Tada, M. Interaction of a carcinogen, 4-nitroquinoline-1-oxide, with nucleic acids: chemical degradation of the adducts. Chem. -Biol. Interact., 3: 225–229, 1971.
44. Takebe, H., Furuyama, J., Miki, Y., and Kondo, S. High sensitivity of xeroderma pigmentosum cells to the carcinogen 4-nitroquinoline-1-oxide. Mutat. Res., 15: 98–100, 1972.
45. Taylor, A.M.R., Harnden, D.G., Arlett, C.F., Harcourt, S.A., Lehmann, A.R., Stevens, S., and Bridges, B.A. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature (Lond.), 258: 427–429, 1975.
46. Taylor, A.M.R., Roshey, C.M., and Cambell.J.B. Unusual sensitivity of ataxia telangiectasia cells to bleomycin. Cancer Res. 39: 1046–1050, 1979.
47. Tong, W.P., and Ludlum, D.B. Formation of the cross-linked base, diguan-ylethane in DNA treated with N,/V’-bis(2-chloroethyl)-N-nitrosourea. Cancer Res., 41: 380–382, 1981.
48. Warren, S.T., Schultz, R.A., Chang, C.C., Wade, M.H., and Trosko, J.E. Elevated spontaneous mutation rate in Bloom syndrome fibroblasts. Proc. Natl. Acad. Sci. U.S.A.78: 3133–3137, 1981.
49. Weksberg, R., Buchwald, M., Sargent, P., Thompson, M.W., and Siminov-itch, L. Specific cellular defects in patients with Fanconi anemia. J. Cell. Physiol., 101:311–323, 1979.
50. Zweiling, L.A., Anderson, T., and Kohn, K.W. DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(ll) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res., 39: 365–369, 1979.